“Mild Clinical Course of COVID-19 Infection in Chronic Myeloid Leukemia (CML) Patients Receiving Tyrosine Kinase Inhibitors (TKIs) Without Interruption”. 2021. Mediterranean Journal of Hematology and Infectious Diseases 13 (1): e2021022. https://doi.org/10.4084/mjhid.2021.022.